Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis factor-alpha and 5-fluorouracil combined treatment.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 7872711)

Published in Anticancer Res on March 30, 1995

Authors

N Tanaka1, J Ohoida, T Matuno, A Gouchim, H Iwagaki, L F Moreira, K Orita

Author Affiliations

1: First Department of Surgery, Okayama University Medical School, Japan.

Articles by these authors

Autopsy findings in early and late postoperative death after partial left ventriculectomy. Ann Thorac Surg (2000) 1.73

Appendiceal mucocele with concomitant colonic cancer. Report of two cases. Dis Colon Rectum (1996) 1.69

Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia (1997) 1.67

Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc (1995) 1.51

Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy. Ann Thorac Surg (1998) 1.41

Generalized peritonitis due to spontaneously perforated pyometra presenting as pneumoperitoneum: report of a case. Surg Today (2000) 1.39

[Synchronous and metachronous tumors of the colon and rectum]. Arq Gastroenterol (1994) 1.37

Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice. Acta Med Okayama (1983) 1.27

Gastric perforation caused by a bulimic attack in an anorexia nervosa patient: report of a case. Surg Today (2000) 1.19

Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol (1998) 1.16

Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J Immunol Methods (1997) 1.15

Evolution of circadian organization in vertebrates. Braz J Med Biol Res (1997) 1.13

Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan. Eur J Cancer (1996) 1.09

Krestin (PSK). Cancer Treat Rev (1984) 1.03

Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc (1996) 1.01

Laparoscopic versus open cholecystectomy in cirrhotic patients: a prospective study. Surg Laparosc Endosc (1997) 1.00

The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J Cancer Res Clin Oncol (1996) 0.99

Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int J Cancer (1993) 0.98

Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg (2000) 0.97

Comparison of patterns of rejection in multivisceral transplantation and abdominal organ cluster transplantation in pigs. Transplant Proc (1994) 0.95

Functional expression of Fas and Fas ligand on human intestinal intraepithelial lymphocytes. Clin Exp Immunol (1999) 0.95

Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines. Leukemia (2000) 0.95

Primary malignant lymphoma of the breast. With a review of 73 cases among Japanese subjects. Acta Pathol Jpn (1984) 0.94

Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice. Cell Immunol (1999) 0.93

IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. J Immunol (2000) 0.93

Aberration of p53 and DCC in gastric and colorectal cancer. Oncol Rep (2000) 0.92

Human colon cancer cells express the functional Fas ligand. Res Commun Mol Pathol Pharmacol (1998) 0.92

Synchronous colorectal carcinomas. Hepatogastroenterology (1994) 0.92

A case of traumatic neuroma of the gallbladder in the absence of previous surgery and cholelithiasis. Acta Med Okayama (1996) 0.92

Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16. FEBS Lett (2000) 0.92

The importance of family study in the patients with familial adenomatous polyposis. Acta Med Okayama (1994) 0.91

A new hybrid artificial liver using a combination of hepatocytes and biomatrix. ASAIO Trans (1987) 0.91

Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells. J Int Med Res (2001) 0.91

Colorectal cancer after irradiation for cervical cancer--case reports. Anticancer Res (1995) 0.90

Apoptosis in cultured human colon cancer cells induced by combined treatments with 5-fluorouracil, tumor necrosis factor-alpha and interferon-alpha. Jpn J Clin Oncol (1997) 0.89

Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin Exp Immunol (2000) 0.89

Laparoscopic cholecystectomy in cirrhotic patients: expanding indications. Surg Laparosc Endosc (1993) 0.88

Oxygen-dependent inhibition of neutrophil respiratory burst by nitric oxide. Free Radic Res (1996) 0.88

Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. Acta Med Okayama (2000) 0.88

Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin Exp Immunol (1995) 0.88

Natural history and treatment of anorectal strictures complicating Crohn's disease. Br J Surg (1988) 0.88

The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients. Br J Cancer (2001) 0.88

Liposarcoma of stomach: report of a case. Acta Med Okayama (1968) 0.87

Epidermal growth factor receptor in human hepatocellular carcinoma. Cancer Detect Prev (1997) 0.87

Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res (1986) 0.87

Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer. Cancer (1994) 0.86

Decreased expression of DCC mRNA in gastric and colorectal cancer. Surg Today (1995) 0.85

Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer: a randomised controlled study. Eur J Cancer (1991) 0.85

Radical block resection of hepatoduodenal ligament for carcinoma of the bile duct with double catheter bypass for portal circulation. Surg Gynecol Obstet (1988) 0.85

The laser treatment of hemorrhoids: results of a study on 1816 patients. Jpn J Surg (1989) 0.85

Right portal embolization before extended right hepatectomy using laparoscopic catheterization of the ileocolic vein: a prospective study. Surg Laparosc Endosc (1994) 0.85

Functional expression of Fas and Fas ligand on human colonic intraepithelial T lymphocytes. J Int Med Res (2000) 0.84

Effect of splenectomy in tumor-bearing mice and gastric cancer patients. Gan (1977) 0.84

Preoperative cell-mediated immune status of gastric cancer patients. Cancer (1976) 0.84

Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res (1995) 0.84

IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC. Cell Immunol (2001) 0.84

Validation of a cutoff value on echo Doppler analysis to replace right heart catheterization during pulmonary hypertension evaluation in heart transplant candidates. Transplant Proc (2010) 0.84

Kupffer cell function in chronic liver injury and after partial hepatectomy. Res Exp Med (Berl) (1994) 0.83

Ovarian metastasis in patients with colorectal carcinoma. Acta Med Okayama (1994) 0.83

Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells. J Immunol (2000) 0.83

The enhancement of cell surface ICAM-I and HLA class I antigens in human gastric cancer cell lines by IFN-gamma. Acta Med Okayama (1994) 0.83

Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor. J Int Med Res (2002) 0.83

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization. Cancer (1992) 0.83

[Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method]. Gan To Kagaku Ryoho (1983) 0.82

Apoptosis in acute tubular necrosis and acute renal allograft rejection. Transplant Proc (1994) 0.82

Induction of antiidiotypic antibodies by donor-specific blood transfusions. Establishment of a human-mouse hybridoma secreting the MLR-inhibiting factor. Transplantation (1989) 0.82

Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol (1995) 0.82

Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression. Jpn J Cancer Res (1991) 0.82

Interruption of hepatic arterial blood flow after resection of pancreaticobiliary carcinoma. Hepatogastroenterology (1996) 0.82

An immuno-polymerase chain reaction assay for human interleukin-18. J Immunol Methods (2000) 0.82

Lateral lymph node dissection for rectal carcinoma below the peritoneal reflection. Br J Surg (1994) 0.82

Effects of gastrectomy on motility, perfusion pressure, and caerulein-induced relaxation of sphincter of Oddi in dogs. J Smooth Muscle Res (1994) 0.82

Preventive and antiproliferative effects of tumor necrosis factor against experimental hepatic metastases of mouse colon-26 tumor. Jpn J Cancer Res (1989) 0.82

A new slow delivery type of superoxide dismutase prevents warm ischemia damage in swine orthotopic liver transplantation. Transplant Proc (1991) 0.81

Immunopathologic and histologic studies on benign recurrent hematuria. Clinicopathologic similarities with IgA nephropathy. Am J Pathol (1979) 0.81

Increased plasma GlyCAM-1, a mouse L-selectin ligand, in response to an inflammatory stimulus. J Leukoc Biol (1996) 0.81

Needle tract implantation of hepatocellular carcinoma after ultrasonically guided needle liver biopsy: a case report. Hepatogastroenterology (1996) 0.81

Right internal thoracic artery through the transverse sinus in myocardial revascularization. Ann Thorac Surg (1996) 0.81

[The expression of neural cell adhesion molecule (NCAM), neural invasion and recurrence patterns in rectal cancer--a study using anti-NACM (neural cell adhesion molecule) antibody]. Nihon Geka Gakkai Zasshi (1994) 0.81

The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma. J Neural Transm (Vienna) (2001) 0.81

Blood cardioplegia with warm reperfusion versus intermittent aortic crossclamping in myocardial revascularization. Randomized controlled trial. J Thorac Cardiovasc Surg (1993) 0.81

Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I. Cancer Immunol Immunother (1984) 0.81

Submucosal lipoma synchronous with an early gastric cancer. J Clin Gastroenterol (1992) 0.81

A case of superior lumbar hernia. Jpn J Surg (1991) 0.81

Antiproliferative effects of natural human tumor necrosis factor-alpha, interferon-alpha, and interferon-gamma on human pancreatic carcinoma cell lines. Int J Pancreatol (1991) 0.81

Equivalence of the acute cytokine surge and myocardial injury after coronary artery bypass grafting with and without a novel extracorporeal circulation system. J Int Med Res (2005) 0.81

Expression of the interleukin 2 receptor beta chain (p75) in renal transplantation--applicability of anti-interleukin-2 receptor beta chain monoclonal antibody. Transplantation (1991) 0.81